• Magazine
  • ENEWS
  • SUBSCRIBE
  • WEBINARS
  • PODCASTS
  • EBOOKS
    • Nov 23, 2024Neurogene reports patient death in Rett syndrome gene therapy trial | Halozyme withdraws acquisition proposal for Evotec
    Nov 22, 2024BeiGene settles patent case over B-cell malignancy treatment | Samsung Biologics signs manufacturing deals worth $668M with European company
    Nov 21, 2024Pfizer names new research and development leadership | Jupiter Bioventures launches with $70M to develop biotech companies
    Nov 20, 2024FDA grants Regenxbio accelerated approval pathway for Duchenne gene therapy | Sanofi invests $42M in Lyon for drug production
    Nov 19, 2024Neurogene halts high-dose Rett syndrome therapy after adverse event | Novartis partners with Ratio on SSTR2 therapy
    Nov 16, 2024EMA recommends Leqembi for treatment of early Alzheimer’s disease | PTC Therapeutics secures FDA approval for neuro gene therapy
    Nov 15, 2024Merck licenses LaNova’s LM-299 for cancer treatment | Kronos Bio ends ovarian cancer program, explores strategic options
    Nov 14, 2024BioNTech to acquire Biotheus | AstraZeneca to invest $3.5 billion in U.S. R&D and manufacturing expansion
    Nov 13, 2024FDA lifts hold on Novavax COVID-19, flu vaccine trials | Roche and Flare partner to develop cancer drugs targeting transcription factors
    Nov 9, 2024 FDA moves to drop oral phenylephrine from OTC decongestants | J&J seeks approval for early-stage myeloma treatment
    Nov 8, 2024Acadia Pharmaceuticals to sell Priority Review Voucher for $150M | Avid Bioservices to be acquired in $1.1B deal
    Nov 7, 2024Royalty Pharma invests $350M in Syndax’s GVHD drug | Court blocks Sun Pharma's JAK inhibitor U.S. launch
    Nov 6, 2024FDA extends review deadline for Merus’ cancer treatment | Intra-Cellular Therapies reveals positive phase 3 data for schizophrenia relapse prevention
    Nov 5, 2024EU to rule on Novo’s $16.5B Catalent takeover | Novo, Ascendis partner on monthly GLP-1 treatment
    Nov 2, 2024FDA says Novo’s lowest weight loss dose is now available | FDA lifts clinical holds on CARsgen’s CAR T-cell therapy trials
    Nov 1, 2024EU fines Teva $491M for blocking MS drug competition | AbbVie, EvolveImmune ink $65M cancer therapy deal
    Oct 31, 2024Biogen and Neomorph partner on molecular glue degraders | AstraZeneca China chief under investigation amid data probe
    Oct 30, 2024GSK acquires autoimmune therapy from Chimagen | MilliporeSigma expands ADC manufacturing in Missouri
    Oct 29, 2024AbbVie to acquire Aliada in $1.4B Alzheimer’s deal | FDA approves Iterum Therapeutics' antibiotic for urinary tract infections
    Oct 26, 2024GSK to invest $800M in Pennsylvania manufacturing expansion | AbbVie and Gedeon Richter team up on new neuro therapies
    Oct 25, 2024Novo Nordisk seeks FDA ban on compounded semaglutide | Roche, Dyno Therapeutics ink $1B neuro gene therapy partnership
    Oct 24, 2024NHS rejects Alzheimer's drug over cost concerns following approval | FDA expands approval of Pfizer's RSV vaccine to high-risk adults
    Oct 23, 2024Samsung Biologics secures $1.24B contract manufacturing deal | FDA issues CRL to Camurus' hormone disorder drug
    Oct 22, 2024 Nucleus RadioPharma expands manufacturing with new sites in AZ and PA | FDA approves Astellas gastric cancer combo
    Oct 19, 2024Baxter shares update on Hurricane Helene impact at NC site | Merck reports positive trial results for RSV antibody
    Latest Edition